睿昂基因
(688217)
| 流通市值：13.72亿 | | | 总市值：13.72亿 |
| 流通股本：5585.59万 | | | 总股本：5585.59万 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 111,923,118.97 | 139,151,947.97 | 133,577,735.53 | 156,451,159.18 |
| 应收票据及应收账款 | 170,086,821.26 | 166,579,027.51 | 182,001,030.26 | 201,793,253.51 |
| 其中：应收票据 | 2,391,878.08 | 650,986.44 | 1,513,487.24 | 367,632 |
| 应收账款 | 167,694,943.18 | 165,928,041.07 | 180,487,543.02 | 201,425,621.51 |
| 应收款项融资 | 4,690,020 | 4,685,850 | 5,432,914 | 4,229,656 |
| 预付款项 | 13,777,712.4 | 7,142,854.31 | 8,930,505.19 | 5,733,602.39 |
| 其他应收款合计 | 1,968,949.8 | 1,859,538.48 | 2,338,735.85 | 1,342,624.69 |
| 存货 | 45,158,971.12 | 43,400,196.2 | 50,851,605.41 | 52,324,702.43 |
| 其他流动资产 | 11,753,235.47 | 13,791,495.07 | 11,143,319.04 | 12,386,236 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 471,364,891.5 | 470,136,956.05 | 484,945,509.17 | 495,856,975.62 |
| 非流动资产: | | | | |
| 长期股权投资 | 159,005.52 | 159,005.52 | - | - |
| 其他权益工具投资 | 47,763,354.76 | 47,763,354.76 | 52,922,360.28 | 47,763,354.76 |
| 其他非流动金融资产 | 20,163,000 | 20,163,000 | 24,000,000 | 24,000,000 |
| 固定资产 | 283,838,963.7 | 291,323,385.2 | 295,750,378.92 | 303,869,774.52 |
| 在建工程 | 70,970,256.6 | 69,938,140.35 | 54,656,282.93 | 48,727,321.64 |
| 使用权资产 | 3,830,668.87 | 4,862,057.41 | 7,242,383.28 | 8,800,880.69 |
| 无形资产 | 38,633,638.87 | 41,060,516.53 | 43,222,944.52 | 44,837,637.72 |
| 商誉 | 11,120,561.81 | 11,120,561.81 | 24,371,898.5 | 24,371,898.5 |
| 长期待摊费用 | 1,823,998.72 | 2,025,503.3 | 2,552,945.11 | 2,954,155.24 |
| 递延所得税资产 | 22,340,393.2 | 20,863,893.75 | 22,579,327.71 | 19,529,571.2 |
| 其他非流动资产 | 5,096,625.33 | 6,285,229.11 | 2,781,238.77 | 3,373,317.97 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 505,740,467.38 | 515,564,647.74 | 530,079,760.02 | 528,227,912.24 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 977,105,358.88 | 985,701,603.79 | 1,015,025,269.19 | 1,024,084,887.86 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 18,212,583.52 | 11,269,327.44 | 11,897,190.49 | 17,170,828.85 |
| 应付账款 | 18,212,583.52 | 11,269,327.44 | 11,897,190.49 | 17,170,828.85 |
| 合同负债 | 1,691,192.08 | 2,119,902.83 | 2,089,948.84 | 2,298,595.91 |
| 应付职工薪酬 | 11,428,440.59 | 10,868,422.57 | 11,673,084.72 | 10,301,915.43 |
| 应交税费 | 4,593,130.55 | 3,285,339.82 | 3,266,721.21 | 1,852,941.69 |
| 其他应付款合计 | 4,526,221.96 | 3,208,803.3 | 3,176,841.49 | 3,217,987.4 |
| 一年内到期的非流动负债 | 3,292,637.21 | 5,413,269.18 | 5,770,399.43 | 6,347,774.93 |
| 其他流动负债 | 400,917.97 | 2,556,161.09 | 1,179,408.22 | 1,546,909.35 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 44,145,123.88 | 38,721,226.23 | 39,053,594.4 | 42,736,953.56 |
| 非流动负债: | | | | |
| 长期借款 | - | 13,750,000 | 15,000,000 | 15,000,000 |
| 租赁负债 | 1,394,716.18 | 1,748,920.35 | 3,538,899.86 | 4,143,500.94 |
| 递延收益 | 1,259,799.68 | 1,344,174.71 | 2,928,549.74 | 3,012,924.77 |
| 递延所得税负债 | 4,432,307.47 | 4,907,809.92 | 5,520,489.8 | 5,948,259.99 |
| 其他非流动负债 | 3,387,509.78 | 4,585,000 | 885,000 | 885,000 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 10,474,333.11 | 26,335,904.98 | 27,872,939.4 | 28,989,685.7 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 54,619,456.99 | 65,057,131.21 | 66,926,533.8 | 71,726,639.26 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 55,855,896 | 55,855,896 | 55,855,896 | 55,855,896 |
| 资本公积 | 732,161,074.7 | 732,161,074.7 | 732,161,074.88 | 732,161,074.88 |
| 减:库存股 | 17,025,758.17 | 17,025,758.17 | 17,025,758.17 | 17,025,758.17 |
| 未分配利润 | 141,619,894.58 | 138,264,881.31 | 159,756,723.14 | 163,251,173.35 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 912,611,107.11 | 909,256,093.84 | 930,747,935.85 | 934,242,386.06 |
| 少数股东权益 | 9,874,794.78 | 11,388,378.74 | 17,350,799.54 | 18,115,862.54 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 922,485,901.89 | 920,644,472.58 | 948,098,735.39 | 952,358,248.6 |
| 负债和股东权益合计 | 977,105,358.88 | 985,701,603.79 | 1,015,025,269.19 | 1,024,084,887.86 |
| 公告日期 | 2025-04-25 | 2025-04-18 | 2024-10-30 | 2024-08-30 |
| 审计意见(境内) | | 带强调事项段的无保留意见 | | |